Ladone Mary Kay 4

What Happened

• Mary Kay Ladone, a director of Inogen, received a grant of 28,081 restricted stock units (RSUs) on June 5, 2026. The Form 4 reports an acquisition price of $0.00 (typical for equity awards); total reported value on the Form 4 is $0.00.
• This is an award/compensation grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-05; Form 4 filed: 2026-06-09 (timely filed within SEC deadlines).
• Price reported: $0.00 per share (award/RSU grant).
• Shares involved: 28,081 RSUs granted.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote: The RSUs vest subject to continued service and will vest on the earlier of (i) the one-year anniversary of the grant or (ii) the day prior to the date of the next Annual Meeting of stockholders following the grant.
• Transaction code: A = Award/Grant.

Context

• RSUs are compensation that convert into actual shares only upon vesting; they are not an immediate cash purchase and do not indicate an immediate sale. Such grants are routine director compensation and should be interpreted as equity-based pay rather than a direct bullish or bearish trading signal.